US0028241000
US0028241000
Abbott Laboratories
Loading chart...
Pure Price Volatility Risk (Market Swings)
The business itself is financially solid (Financial Health 75/100, minimal insolvency risk). The high overall score (6/7) is driven primarily by extreme stock price swings (±23.1% p.a.) and steep historical drawdowns.
Volatility Risk
Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.
Volatility Risk Score
6/7 High
6 / 7 SRI Price Fluctuation & Beta
Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves noticeably less than the broader market (0.6x).
Beta (Market Relation)
0.58x
DefensiveVolatility (5Y p.a.)
23.1% p.a.
5-Year HorizonMax Drawdown (5Y)
-41.6%
5-Year HorizonSharpe Ratio
-0.26
Return / RiskSpeculative / High Risk: Score Basis:
Multi-Horizon Risk & Performance Matrix
Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.
Timeframe | Volatility (p.a.) | Max Drawdown | Sharpe Ratio | Return (p.a.) |
|---|---|---|---|---|
| 1 Year | — | — | — | -26.6% |
| 3 Years | 22.9% | -41.1% | -0.08 | +0.6% |
| 5 Years | 23.1% | -41.6% | -0.26 | -3.6% |
| 10 Years | 24.1% | -41.6% | 0.25 | +8.5% |
Automated Risk & Health Notes (Red Flags)
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
Historical Stress Test: Maximum peak-to-trough drawdown of -41.6% in the extended horizon.
Corporate Governance & ISS Scores
Overall Governance Risk
5 ISS Score: 5 / 10
Audit Risk
9 ISS Score: 9 / 10
Board Risk
6 ISS Score: 6 / 10
Short Ratio
2.48